SCHEMBL292693

SCHEMBL292693

CCCCCCNC(N)=O

nearest known ligand 0.67

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 9/20 0.67
CASP2 P42575 1/20 0.59
ZDHHC20 Q5W0Z9 1/20 0.55
ZDHHC2 Q9UIJ5 1/20 0.55
NAAA Q02083 1/20 0.55
DPP7 Q9UHL4 1/20 0.52
RRM1 P23921 1/20 0.52
SPHK1 Q9NYA1 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80555 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL3789783 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL3055110 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL19468503 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL2185171 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL19468457 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL76613 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL944633 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL19468513 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA
SCHEMBL1820932 1.00 EPHX1 (0.67) EPHX1CASP2ZDHHC20ZDHHC2NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118368985-A Fungicidal compositions 先正达农作物保护股份公司 2024-07-19 CN claimed
CN-118019451-A Fungicidal compositions comprising fludioxonil 先正达农作物保护股份公司 2024-05-10 CN claimed
CN-116745289-A Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor 奥洛治疗有限公司 2023-09-12 CN claimed
US-20230110354-A1 THERAPEUTIC AGENT DELIVERY SYSTEMS AND METHODS OF FORMING AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2023-04-13 US claimed
US-11208361-B2 Technology to coat fertilizer and improve fertilizer efficiency and their associated methods MCKNIGHT GARY DAVID (US) 2021-12-28 US claimed
WO-2021252897-A2 THERAPEUTIC AGENT DELIVERY SYSTEMS AND METHODS OF FORMING AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-12-16 WO claimed
EP-3836971-A1 CONJUGATES AND METHODS OF USING THE SAME Flagship Pioneering Innovations V, Inc. (US) 2021-06-23 EP claimed
US-20210162057-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-06-03 US claimed
WO-2020037009-A1 CONJUGATES AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2020-02-20 WO claimed
CN-110129397-B Preparation method of oyster peptide 烟台源力德海洋生物有限公司 2019-10-25 CN claimed
CN-102713033-A Spandex with high uniformity INVISTA TECH SARL 2012-10-03 CN claimed
CN-102695708-A N1-pyrazolospiroketone acetyl-coA carboxylase inhibitors PFIZER 2012-09-26 CN claimed
US-8263606-B2 Spiro-oxindole compounds and their use as therapeutic agents XENON PHARMACEUTICALS INC. (CA) 2012-09-11 US claimed
EP-2350090-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2011-08-03 EP claimed
CN-101333176-B Method for preparing substituent urea and co-producing hydrochloride of corresponding amines UNIV ZHEJIANG TECHNOLOGY 2011-02-02 CN claimed
US-20100137299-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2010-06-03 US claimed
WO-2010045251-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS, INC. (CA) 2010-04-22 WO claimed
CN-101333176-A Method for preparing substituent urea and co-producing hydrochloride of corresponding amines UNIV ZHEJIANG TECHNOLOGY (CN) 2008-12-31 CN claimed
CN-101250162-A Preparation method of agricultural herbicide YANCHENG LVYE CHEMICAL INDUSTR (CN) 2008-08-27 CN claimed
US-3940370-A Method of making polyureas THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1976-02-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210162057-A1 CONJUGATES AND METHODS OF USING THE SAME CD47, CD44, CD74 EPHX1 1102/4885CASP2 1337/4885ZDHHC20 1692/4885
US-20100137299-A1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS TRPV3, TRPV1, TRPC3 EPHX1 2007/4885CASP2 962/4885ZDHHC20 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.